CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- 4 Grant or award Director acquired 1,438 shares (grant or award)
- 4 Grant or award Director acquired 1,438 shares (grant or award)
- 4 Grant or award Director acquired 1,438 shares (grant or award)
- 8-K Event Executive or director change · Shareholder vote results
- 4 Grant or award Director acquired 1,438 shares (grant or award)
- 4 Grant or award Director acquired 2,845 shares (grant or award)
- 4 Grant or award Director acquired 1,438 shares (grant or award)
- 4 Grant or award Director acquired 1,888 shares (grant or award)
- 4 Grant or award Director acquired 1,438 shares (grant or award)
- 4 Grant or award Director acquired 1,973 shares (grant or award)
- 4 Grant or award Director acquired 1,438 shares (grant or award)
- 4 Grant or award Director acquired 1,860 shares (grant or award)
- SD Other Specialized Disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Grant or award EVP & Chief Financial Officer acquired 21,112 shares (grant or award)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 4 of 123 · 2,446 filings